A BELGIAN PILOT PROJECT TESTING THE FEASIBILITY AND ACCEPTABILITY OF SHORT MESSAGE SERVICE (SMS) TEXT MESSAGING TO PATIENTS TREATED WITH QUETIAPINE
Author(s)
Paul Lodewyck, Neuropsychiatre, Neuropsychiatre1, Denis Volcke, MD, Doctor2, Piet Snoeck, MD, Doctor3, Tom Festjens, MD, Doctor4, Guy Vandenhoven, MD, Medical Director5, An Matthys, MD, Therapeutic Area Leader51Psychiatric Ziekenhuis Heilige Familie, Kortrijk, Belgium; 2 Kliniek OLV van Lourdes, Waregem, Belgium; 3 Stedelijk Ziekenhuis, Roeselare, Belgium; 4 Stedelijk Ziekenhuis, Roeselaere, Belgium; 5 AstraZeneca Belgium, Brussels, Belgium
OBJECTIVES: To investigate the feasibility, and patient/psychiatrist acceptability, of sending medication reminders and well-being questions to patients receiving quetiapine via SMS-messages. METHODS: This study was conducted by 7 Belgian psychiatrists in outpatients receiving quetiapine according to local label and considered capable of using their cellular-phone and sending SMS-messaging. Twenty-seven outpatients (11 male; 16 female, mean age: 35.3 years) were followed for 8 to12 weeks in this psychiatrist assessed, pilot-study. Patients received SMS-messages twice daily to remind them to take their medication and enquire about their well-being, fun messages could be received optionally. Patients' response was monitored by psychiatrists via a website, and subsequently used to assess technical feasibility. RESULTS: Patients responded to 77% of the SMS-messages (of which 84% total response, 13% inaccurate response, 3% late response). Twenty patients completed the study. The mean study duration was 9.4 weeks. Response was higher in patients who were supported in their disease by family/friends and who showed good motivation. More than 50% of the patients rated the degree of support offered by SMS as valuable (to a significant/reasonably extent). 71% appreciated the fun messages. The 2 major benefits expressed by the patients were the feeling of being cared for (n=11/21) and the reminding to take their medication (n=7/21). Most of the psychiatrists felt that the system helped improve compliance and relationship with the patient. Psychiatrists felt the system was valuable to 19/22 patients, 16/24 patients remained compliant with the system and 16/22 patients felt the frequency of SMS-messages was acceptable. There was a strong correlation between patients giving positive well-being responses and SMS-compliance (R Pearson=0.72, p<0.001). CONCLUSION: The technology was favorably accepted and performed well. The high levels of SMS-compliance and benefits expressed by patients and psychiatrists support a larger-scale assessment of this possibility for assistance to healthcare providers and patients.
Conference/Value in Health Info
2007-10, ISPOR Europe 2007, Dublin, Ireland
Value in Health, Vol. 10, No. 6 (November/December 2007)
Code
PMH50
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Mental Health